News from NYU Langone Health
NYU Langone Health Appoints 1st Cardiac Surgery Chief. (Becker's Hospital Review)
(4/10) NYU Langone Health has appointed Noritsugu Naito, MD, as the first chief of cardiac surgery at NYU Langone Hospital-Brooklyn, and clinical associate professor, Department of Cardiothoracic Surgery at NYU Grossman School of Medicine, following an expansion of cardiology services at the hospital.
Mergers Drive Identity Overhauls At Hospitals. (Becker's Hospital Review)
(4/10) Healthcare mergers and acquisitions are anticipated to rebound in 2025, despite a 9% decline from 2023 to 2024, with recent examples including NYU Langone Health’s acquisition of Patchogue, N.Y.-based Long Island Community Hospital, now operating as NYU Langone Hospital–Suffolk.
Multidisciplinary BiTE-Associated AE Education Increases The Safety Of Outpatient Administration. (OncLive)
(4/10) NYU Langone Health’s Perlmutter 鶹Ƶapp Center has successfully implemented patient and healthcare education methods and enhanced monitoring strategies for administering bispecific T-cell engager (BiTE) therapies, as detailed in a study presented at the 50th Annual Oncology Nursing Society Congress; this initiative has facilitated BiTE administration in both inpatient and outpatient settings, with therapies like teclistamab-cqyv and epcoritamab being among those administered, while collaboration between disciplines and improved electronic health record alerts have been integral in managing toxicities such as cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome.
Pridopidine Beneficial In Subset Of Patients With Huntington’s. (Healio)
(4/10) At the American Academy of Neurology Annual Meeting in San Diego, Andrew S. Feigin, MD, adjunct professor, Department of Neurology, and associate chair, NYU Network and Clinical Research, Department of Neurology, presented findings from the PROOF-HD trial indicating that pridopidine improved clinical progression, cognition, and motor function in Huntington’s disease patients not taking antidopaminergic medications, noting, “The presence of ADMs seems to mask the beneficial effects of pridopidine.”
Should We Be Bringing Back Extinct Species? Ethical Concerns Raised After Dire Wolf Allegedly Resurrected. (ABC News)
(4/11) Colossal Laboratories & Biosciences, a Dallas-based biotechnology company, announced the genetic engineering of animals resembling the extinct dire wolf, claiming it as a “scientific breakthrough for global conservation efforts,” though experts, including Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, expressed ethical concerns about their survival and integration into modern ecosystems, saying, “If you bring back something that’s been dead 10,000 or 40,000 or 100,000 years, you need to bring back its environment, not just the animal.”
The CDC Lowers Recommended Age For Pneumonia Vaccine. (FOX News Radio)
(4/10) The Centers for Disease Control and Prevention (CDC) has lowered the recommended age for adults to receive a pneumonia vaccine from 65 to 50 to better protect against pneumococcal disease when it is most dangerous, and medical specialists are now suggesting adults receive a measles vaccine booster shot; Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, said he understands the CDC’s decision, provided tips for staying healthy while traveling, and shared insights from his interview with the head of the WHO.
Stroke, Dementia And Depression Share These 17 Preventable Risk Factors. (Fox News)
(4/10) A study by Mass General Brigham identified 17 shared risk factors for stroke, dementia, and late-life depression, which can be mitigated through lifestyle changes such as managing blood pressure and staying socially engaged, according to Sanjula Singh, MD, PhD, principal investigator at Massachusetts General Hospital; Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, supported the study’s findings, stating, “These factors are all well-proven to decrease inflammation in the body and thereby the risk of stroke, dementia and late-life depression.”
